Human medicines European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Krka, efavirenz,emtricitabine,tenofovir disoproxil, Date of authorisation: 08/02/2018, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Ztalmy, ganaxolone, Date of authorisation: 26/07/2023, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Teriflunomide Accord, teriflunomide, Date of authorisation: 09/11/2022, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Aubagio, teriflunomide, Date of authorisation: 26/08/2013, Revision: 28, Status: Authorised

2024 annual workshop of the European network of paediatric research at EMA (Enpr-EMA) , Online, European Medicines Agency, Amsterdam, the Netherlands, from 2 October 2024, 09:00 (CEST) to 2 October 2024, 17:00 (CEST)

List of medicines under additional monitoring

List of medicinal products under additional monitoring

List of medicinal products under additional monitoring

Human medicines European public assessment report (EPAR): Skyrizi, risankizumab, Date of authorisation: 26/04/2019, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Sarclisa, isatuximab, Date of authorisation: 30/05/2020, Revision: 11, Status: Authorised